Financials Ilsung Is Co., Ltd.

Equities

A003120

KR7003120003

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
19,710 KRW -0.05% Intraday chart for Ilsung Is Co., Ltd. -0.66% -16.66%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 128,464 110,323 111,130 99,170 125,151 164,817
Enterprise Value (EV) 1 74,549 58,483 66,326 35,265 -174,506 -70,366
P/E ratio 43.6 x 16.9 x 39.4 x -82.8 x 1.2 x -7.9 x
Yield - - - - - -
Capitalization / Revenue 2.08 x 2.28 x 2.74 x 2.36 x 2.04 x 2.11 x
EV / Revenue 1.21 x 1.21 x 1.63 x 0.84 x -2.85 x -0.9 x
EV / EBITDA 14.1 x 32 x 59.7 x 27.6 x -39.7 x 14.3 x
EV / FCF 4.65 x 6.88 x -28.6 x -7.82 x -1.29 x 6.31 x
FCF Yield 21.5% 14.5% -3.49% -12.8% -77.5% 15.9%
Price to Book 0.4 x 0.36 x 0.37 x 0.33 x 0.28 x 0.42 x
Nbr of stocks (in thousands) 6,719 6,719 6,719 6,719 7,414 6,969
Reference price 2 19,120 16,420 16,540 14,760 16,880 23,650
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 61,653 48,412 40,601 42,090 61,248 78,053
EBITDA 1 5,272 1,828 1,111 1,276 4,391 -4,907
EBIT 1 2,258 -1,257 -1,948 -1,797 1,297 -7,993
Operating Margin 3.66% -2.6% -4.8% -4.27% 2.12% -10.24%
Earnings before Tax (EBT) 1 4,587 9,179 4,417 -1,523 137,973 -21,345
Net income 1 2,946 6,719 3,220 -1,368 105,241 -20,941
Net margin 4.78% 13.88% 7.93% -3.25% 171.83% -26.83%
EPS 2 438.4 971.7 419.9 -178.3 14,104 -2,994
Free Cash Flow 1 16,019 8,499 -2,317 -4,509 135,215 -11,160
FCF margin 25.98% 17.56% -5.71% -10.71% 220.77% -14.3%
FCF Conversion (EBITDA) 303.87% 465% - - 3,079.15% -
FCF Conversion (Net income) 543.85% 126.5% - - 128.48% -
Dividend per Share - - - - - -
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 53,916 51,840 44,804 63,905 299,657 235,182
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 16,019 8,499 -2,317 -4,509 135,215 -11,160
ROE (net income / shareholders' equity) 0.91% 2.01% 0.93% -0.39% 26.6% -5.04%
ROA (Net income/ Total Assets) 0.41% -0.22% -0.33% -0.3% 0.19% -1.09%
Assets 1 724,964 -3,065,032 -979,994 452,069 56,218,584 1,924,007
Book Value Per Share 2 48,272 45,051 45,310 45,106 60,097 56,158
Cash Flow per Share 2 207.0 4,861 4,723 6,630 36,811 23,488
Capex 1 1,209 1,240 4,817 10,930 62,011 7,727
Capex / Sales 1.96% 2.56% 11.87% 25.97% 101.25% 9.9%
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A003120 Stock
  4. Financials Ilsung Is Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW